-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
IOM
November 30, 2010
Today the Institute of Medicine (IOM) released updated recommendations regarding calcium and vitamin D intake. IOM recommends 600 international units (IU) of vitamin D every day for most healthy adults under age 71 and 800 IU for healthy people age 71 and older. The updated IOM recommendations for vitamin D intake are sufficient for most healthy adults, however, some adults may need more.
NOF
Washington, DC
October 14, 2010
WASHINGTON, DC (October 14, 2010) — Osteoporosis is a serious, widespread and growing public health threat, according to the National Osteoporosis Foundation (NOF). NOF welcomes any new FDA approved treatment options, such as AtelviaTM, that will help patients address this prevalent disease. NOF estimates 10 million Americans have osteoporosis and another 34 million are at risk for the disease.
FDA
October 13, 2010
Labeling change adds warning about possible risks of long-term use of osteoporosis drugs
The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk.
To read more visit, http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229171.htm
NOF
October 12, 2010
The Bone Health Challenge kicks-off on World Osteoporosis Day, October 20th, connecting women everywhere to the leading bone health resources in the nation
NOF
Washington, DC
September 28, 2010
WASHINGTON, DC (September 28, 2010) - NOF has been approved as a provider of continuing education for nurses (CNE) by the American Nurses Credentialing Center (ANCC) for a period of two years. ANCC’s Accreditation Program specifies a comprehensive set of educational design criteria to ensure that continuing education activities are effectively planned, implemented, and evaluated according to educational standards and adult learning principles. ANCC accreditation of a continuing nursing education program is the hallmark of quality.
NBC
September 24, 2010
While a concerted effort to boost research on women's health over the last two decades has lessened the burden cardiovascular disease, breast cancer and cervical cancer, the effort has yielded less progress on other fronts. NBC's Robert Bazell reports.
NOF
September 21, 2010
(Washington, DC) — The National Coalition for Osteoporosis and Related Bone Diseases applauds Rep. Berkley (D-NV), Rep. Burgess (R-TX) and the more than 60 Members of Congress who have joined together to introduce the Bone Health Promotion and Research Act of 2009. "We are pleased to have bipartisan support for this timely legislation which will educate Americans about achieving better bone health as well as help people who suffer from debilitating bone diseases, fulfilling the call to action from the Surgeon General's 2004 Report on, Bone Health and Osteoporosis," stated Ethel S.
NOF
September 21, 2010
What is the concern?
Researchers have been looking into a possible link between the use of bisphosphonate medicines, such as alendronate (Fosamax®), ibandronate (Boniva®), risedronate (Actonel®) and zoledronic acid (Reclast®) and an unusual type of broken bone in the femur (thigh bone). Bisphosphonate medicines are prescribed to reduce the risk of fractures (broken bones) in people with osteoporosis.
NOF
September 13, 2010
What is the concern?
Researchers have been looking into a possible link between the use of oral bisphosphonate medications, such as alendronate (Fosamax®), ibandronate (Boniva®) and risedronate (Actonel®) and an increased risk of esophageal cancer. Bisphosphonate medications are prescribed to reduce the risk of fractures (broken bones).
Washington, DC
August 27, 2010
WASHINGTON, DC (August 26, 2010) - The National Osteoporosis Foundation (NOF) mourns the passing of Lawrence G. Raisz, MD, long time member of the NOF Board of Trustees, who served as the NOF Vice President until the time of his death. Dr. Raisz's service to NOF was extensive. He played a critical role in the organization from its inception; first as Chair of the Scientific Advisory Board and subsequently as a member of the Board of Trustees. While serving as Vice President, Dr.
